浅沼 宏

Medicine & Life Sciences

1. Kidney 100%
2. Prostatectomy 96%
3. Vesico-Ureteral Reflux 58%
4. Renal Cell Carcinoma 56%
5. Nephrectomy 55%
6. Recurrence 50%
7. Adrenalectomy 47%
8. Prostatic Neoplasms 44%
9. Prostate-Specific Antigen 40%
10. Kidney Transplantation 38%
11. Urinary Bladder 37%
12. Urinary Bladder Neoplasms 32%
13. Neoplasms 32%
14. Salvage Therapy 31%
15. Therapeutics 30%
16. Hydronephrosis 30%
17. Interleukin-18 29%
18. Child 28%
19. Photochemotherapy 27%
20. Pediatrics 27%
21. 13,17-bis(1-carboxypropionyl)carbamoylethyl-3-ethenyl-8-ethoxyiminoethylidene-7-hydroxy-2,7,12,18-tetramethyl porphyrin 26%
22. Ureter 26%
23. Transplant Recipients 25%
24. Cystoscopy 24%
25. Hypospadias 24%
26. Disorders of Sex Development 22%
27. C-Reactive Protein 22%
28. Hematuria 20%
29. Cyclosporine 20%
30. Living Donors 19%
31. Transplants 19%
32. Cystine 19%
33. Ureteral Obstruction 19%
34. Castration 18%
35. Androgens 18%
36. Neoplasm Grading 17%
37. Survival 17%
38. Fibrosis 17%
39. Prostate 17%
40. Glomerular Filtration Rate 17%
41. Ultrasonography 16%
42. Body Mass Index 16%
43. dehydroxymethylepoxyquinomicin 15%
44. Newborn Infant 15%
45. Photosensitizing Agents 15%
46. Ureterocele 15%
47. Blood Proteins 15%
48. Urinary Tract Infections 15%
49. Urography 15%
50. Mesenchymal Stem Cells 15%